Naohiro Izumi1, Taiji Nagaoka2,3, Fumihiko Mori1, Eiichi Sato1, Atsushi Takahashi1, Akitoshi Yoshida1. 1. Department of Ophthalmology, Asahikawa Medical College, Asahikawa, Japan. 2. Department of Ophthalmology, Asahikawa Medical College, Asahikawa, Japan. nagaoka@asahikawa-med.ac.jp. 3. Departments of Ophthalmology and Surgery, Scott & White Eye Institute, Texas A&M University Health Science Center, Temple, TX, USA. nagaoka@asahikawa-med.ac.jp.
Abstract
PURPOSE: Nitric oxide (NO) plays an important role in homeostatic vasodilation and the regulation of blood flow. On the other hand, excess release of NO causes various vascular complications. There are only a few reports on the relationship between plasma NO levels and microvascular complications, especially diabetic retinopathy (DR) in patients with type 2 diabetes. The purpose of this study was to determine the relationship between plasma NO levels and DR. METHODS: In a prospective study, blood samples were obtained from 36 patients with diabetes and no diabetic retinopathy (NDR), 43 patients with nonproliferative diabetic retinopathy (NPDR), 18 patients with proliferative diabetic retinopathy (PDR), and 40 subjects without diabetes mellitus, who served as controls. The levels of plasma NOx (nitrite and nitrate), the stable metabolites of NO, were measured by high-performance liquid chromatography with the Griess method. RESULTS: The plasma NOx levels were 92.8 +/- 16.0, 70.2 +/- 6.8, 90.3 +/- 9.1, and 53.8 +/- 6.1 micromol/l in patients with NDR, NPDR, or PDR, and in the controls, respectively. The plasma NOx levels in the three diabetic groups were significantly higher than those in the control group (P < 0.05 in each case). CONCLUSION: The increased plasma NO levels in patients with type 2 diabetes indicate that NO may be associated with the pathogenesis of DR. Copyright Japanese Ophthalmological Society 2006.
PURPOSE:Nitric oxide (NO) plays an important role in homeostatic vasodilation and the regulation of blood flow. On the other hand, excess release of NO causes various vascular complications. There are only a few reports on the relationship between plasma NO levels and microvascular complications, especially diabetic retinopathy (DR) in patients with type 2 diabetes. The purpose of this study was to determine the relationship between plasma NO levels and DR. METHODS: In a prospective study, blood samples were obtained from 36 patients with diabetes and no diabetic retinopathy (NDR), 43 patients with nonproliferative diabetic retinopathy (NPDR), 18 patients with proliferative diabetic retinopathy (PDR), and 40 subjects without diabetes mellitus, who served as controls. The levels of plasma NOx (nitrite and nitrate), the stable metabolites of NO, were measured by high-performance liquid chromatography with the Griess method. RESULTS: The plasma NOx levels were 92.8 +/- 16.0, 70.2 +/- 6.8, 90.3 +/- 9.1, and 53.8 +/- 6.1 micromol/l in patients with NDR, NPDR, or PDR, and in the controls, respectively. The plasma NOx levels in the three diabetic groups were significantly higher than those in the control group (P < 0.05 in each case). CONCLUSION: The increased plasma NO levels in patients with type 2 diabetes indicate that NO may be associated with the pathogenesis of DR. Copyright Japanese Ophthalmological Society 2006.
Authors: K Maejima; S Nakano; M Himeno; S Tsuda; H Makiishi; T Ito; A Nakagawa; T Kigoshi; T Ishibashi; M Nishio; K Uchida Journal: J Diabetes Complications Date: 2001 May-Jun Impact factor: 2.852
Authors: C J Moravski; D J Kelly; M E Cooper; R E Gilbert; J F Bertram; S Shahinfar; S L Skinner; J L Wilkinson-Berka Journal: Hypertension Date: 2000-12 Impact factor: 10.190
Authors: R E Gilbert; D J Kelly; A J Cox; J L Wilkinson-Berka; J R Rumble; T Osicka; S Panagiotopoulos; V Lee; E C Hendrich; G Jerums; M E Cooper Journal: Diabetologia Date: 2000-11 Impact factor: 10.122
Authors: Anderson Martins Tavares; Jaslana Hainfellner Silva; Christiane de Oliveira Bensusan; Andrea Claudia Freitas Ferreira; Livia Pinto de Lima Matos; Kleber Luiz de Araujo E Souza; Luciene de Carvalho Cardoso-Weide; Giselle Fernandes Taboada Journal: PLoS One Date: 2019-05-01 Impact factor: 3.240
Authors: Adolfo Daniel Rodríguez-Carrizalez; José Alberto Castellanos-González; Esaú César Martínez-Romero; Guillermo Miller-Arrevillaga; David Villa-Hernández; Pedro Pablo Hernández-Godínez; Genaro Gabriel Ortiz; Fermín Paul Pacheco-Moisés; Ernesto Germán Cardona-Muñoz; Alejandra Guillermina Miranda-Díaz Journal: J Diabetes Date: 2013-08-21 Impact factor: 4.006
Authors: Adolfo Daniel Rodríguez-Carrizalez; José Alberto Castellanos-González; Esaú César Martínez-Romero; Guillermo Miller-Arrevillaga; Fermín Paul Pacheco-Moisés; Luis Miguel Román-Pintos; Alejandra Guillermina Miranda-Díaz Journal: Redox Rep Date: 2015-08-31 Impact factor: 4.412